Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Savior Lifetec Corporation (4167:TWSE), powered by AI.
Savior Lifetec Corporation is currently trading at $19.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Savior Lifetec Corporation on Alpha Lenz.
View Savior Lifetec Corporation's valuation metrics on Alpha Lenz.
“Savior Lifetec Corporation's ROE is 14.7%. Explore profitability and growth together.”
Ask for details →Savior Lifetec Corporation is a biotechnology and healthcare company specializing in the development, production, and supply of sterile active pharmaceutical ingredients (APIs) and finished dosage formulations, notably for injectable medicines. Focused on specialty injectables, the company’s product portfolio includes a range of carbapenem antibiotics, such as imipenem, meropenem, and ertapenem, as well as other pharmaceutical compounds like paliperidone palmitate and prucalopride succinate. With vertically integrated, state-of-the-art manufacturing facilities and GLP-compliant R&D centers, Savior Lifetec Corporation emphasizes quality, innovation, and regulatory compliance, serving both domestic and international pharmaceutical markets. Founded in 1993 and based in Miaoli County, Taiwan, Savior Lifetec plays a vital role in advancing the pharmaceutical industry by providing essential injectable drugs that support hospital and clinical needs, contributing to global health and medication accessibility.
“Savior Lifetec Corporation's ROE is 14.7%. Explore profitability and growth together.”
Ask for details →Savior Lifetec Corporation (ticker: 4167) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 19.95 with a P/E ratio of -x and P/B of -x.
ROE is 14.75% and operating margin is 16.50%. Annual revenue is $1.2B.